ELC Group
ELC Group is a life sciences consulting firm offering regulatory, compliance, product development, and market access services to pharmaceutical, medical device, and consumer healthcare companies, now operating as an integrated unit within ProductLife Group.
- Company typePrivate
- Founded2004
- HeadquartersKarolinka, Czechia
- Headcount101–250
- GTM typeB2B
- OfferingServices
What ELC Group does
ELC Group is a private life sciences consulting and professional services firm founded in 2004 and headquartered in Karolinka, Czech Republic, with 101-250 employees. The firm delivers specialized regulatory, compliance, and product development services to pharmaceutical, biotechnology, medical device, and consumer healthcare companies across global markets. Its service portfolio spans five categories: Product Development (biopharmaceutical drug development, medical device and MedTech services, consumer healthcare including nutraceuticals, cosmetics, and dermatological solutions), Market and Patient Access Services (policy and advocacy, pricing strategy, health technology assessment, health economics and outcomes research, public affairs, and patient programs), Life Cycle Management (regulatory affairs and operations, quality and compliance, safety and vigilance), Strategy & Digital (strategic consulting, business transformation and commercial excellence, digital and IT services), and Innovation (digital innovation and healthcare and medical innovation). ELC Group operates as a B2B professional services business with a sales-led go-to-market model, engaging enterprise clients through direct relationships and project-based contracts. Revenue is generated through quote-based consulting engagements; no publicly disclosed pricing exists. The firm has been integrated into ProductLife Group (Groupe ProductLife S.A.), a privately held healthcare services parent, with all former ELC Group content migrated to the ProductLife Group website, indicating absorption rather than continued independent operations. No proprietary technology, AI capabilities, patents, certifications, or notable partnerships are disclosed in the available data. Leadership is led by CEO Marco Rubenstein.
ELC Group firmographics
Firmographics- Name
- ELC Group
- Legal name
- ELC Group
- Website
- https://elc-group.com
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- ELC Group is a life sciences consulting firm offering regulatory, compliance, product development, and market access services to pharmaceutical, medical device, and consumer healthcare companies, now operating as an integrated unit within ProductLife Group.
- Ownership category
- akta.pro rank
ELC Group industry classification
Industry- Product category
- Life Sciences Consulting Services
- NAICS
- Management Consulting Services (54161)
- SIC
- Services-Management Consulting Services (8742)
- akta.pro primary industry
- KOL Engagement & Medical Education (Advisory Boards/CME Support) (HLAGALAM)
Keywords
Where ELC Group is headquartered
LocationHeadquarters
- HQ city
- Karolinka
- HQ country
- Czechia
- HQ region
- Europe
Offices1 record
Markets served
ELC Group business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Professional Services: Revenue generated through consulting and specialized services across product development, market access, regulatory affairs, quality compliance, safety vigilance, and strategic digital services for the pharmaceutical and healthcare industries.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
ELC Group product offering
Product offeringCore offering
ELC Group delivers consulting and specialized services across the pharmaceutical, medical device, and consumer healthcare industries. Its offering spans product development (biopharmaceutical drug development, medical device/MedTech, nutraceuticals, cosmetics/dermatological), market and patient access services (policy, pricing, HTA, health economics, patient programs), life cycle management (regulatory affairs, quality/compliance, safety/vigilance), strategy & digital (consulting, business transformation, IT services), and innovation (digital and medical innovation). The company's offerings are now delivered through its parent, ProductLife Group.
Product overview
ELC Group is a life sciences consulting and services company offering an integrated portfolio of five service categories delivered through ProductLife Group. The portfolio includes Product Development (biopharmaceutical, medical device, and consumer healthcare services), Market and Patient Access Services (policy, pricing, HTA, and patient programs), Life Cycle Management (regulatory affairs, quality, safety), Strategy & Digital (consulting, transformation, IT services), and Innovation (digital and medical innovation). Former ELC Group information has been integrated into the ProductLife Group website.
Differentiator
Problem solved
Functional benefit
Companies that use ELC Group
Customer profileSegments4 records
Ideal customer profiles4 records
ELC Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
ELC Group partnerships and signals
Strategic signalRecent moves2 records
Expansion highlights4 records
ELC Group competitors and assessment
Company assessmentDirect peers
- Premier Research: Specialty CRO providing regulatory, clinical, and medical affairs services with particular strength in rare disease and MedTech — directly comparable niche competitor to ELC Group.
- Certara, Inc. Scientific and regulatory consulting firm providing model-informed drug development, regulatory submissions, and HEOR services. Highly comparable to ELC Group's regulatory affairs and health economics offerings.
- PharmaLex (Cencora): Specialized regulatory affairs, pharmacovigilance, and quality compliance consulting firm acquired by Cencora (formerly AmerisourceBergen). Closest direct competitor to ELC Group's core regulatory and safety vigilance practice.
- Parexel International: Global CRO with regulatory, clinical, pharmacovigilance, and market access services. Comparable service mix spanning product development through lifecycle management for pharma and MedTech clients.
- Worldwide Clinical Trials: Mid-sized global CRO with regulatory, clinical, and pharmacovigilance services for biopharma and MedTech — comparable size segment and service mix to ELC Group's specialized practice.
- Medpace Holdings: Mid-to-large CRO providing clinical development, regulatory affairs, and pharmacovigilance services with a similar B2B professional services model to ELC Group.
- ICON plc: Global CRO with dedicated regulatory affairs, pharmacovigilance, and consulting services for pharma and biotech. Direct competitor for ELC Group's lifecycle and regulatory offerings at significantly greater scale.
- ProPharma Group: Specialist regulatory compliance, pharmacovigilance, and quality consulting firm for pharma, biotech, and medical device companies. Highly comparable mid-sized specialist competitor.
Broad incumbents
- Charles River Laboratories: Broadly diversified CRO with regulatory and safety assessment services alongside preclinical and clinical offerings. Overlaps ELC Group on the regulatory and lifecycle management service lines.
Others
- IQVIA: Largest global life sciences services company with regulatory, HTA, HEOR, pharmacovigilance, and market access capabilities — overlaps ELC Group across most service lines but operates at vastly greater scale and breadth.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
ELC Group social profiles
Digital presenceELC Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
ELC Group leadership team
Management profileNumber of profiles
Profiles1 record
ELC Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ELC Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ELC Group
What does ELC Group do?
ELC Group delivers consulting and specialized services across the pharmaceutical, medical device, and consumer healthcare industries. Its offering spans product development (biopharmaceutical drug development, medical device/MedTech, nutraceuticals, cosmetics/dermatological), market and patient access services (policy, pricing, HTA, health economics, patient programs), life cycle management (regulatory affairs, quality/compliance, safety/vigilance), strategy & digital (consulting, business transformation, IT services), and innovation (digital and medical innovation). The company's offerings are now delivered through its parent, ProductLife Group.
Is ELC Group a public or private company?
ELC Group is a private company. It is classified as corporate owned and is currently operating.
When was ELC Group founded?
ELC Group was founded in 2004. It employs 101 to 250 people.
Where is ELC Group based?
ELC Group is headquartered in Karolinka, Czechia, in the Europe region.
How does ELC Group make money?
One revenue line is on record: professional Services.
Who are ELC Group's main competitors?
Direct peers on record are Premier Research, Certara, Inc., PharmaLex (Cencora), Parexel International, Worldwide Clinical Trials, Medpace Holdings, ICON plc and ProPharma Group. Charles River Laboratories is listed as a broad incumbent. IQVIA is listed as an others.
Does ELC Group have an API?
No public API is recorded for ELC Group.
What industry is ELC Group in?
ELC Group's product category is Life Sciences Consulting Services. Its primary akta.pro industry code is HLAGALAM, KOL Engagement & Medical Education (Advisory Boards/CME Support). Its NAICS code is 54161 and its SIC code is 8742.